Literature DB >> 16470154

Thrombosis in children with malignancy.

Laszlo Bajzar1, Anthony K Chan, Mary Patricia Massicotte, Lesley G Mitchell.   

Abstract

PURPOSE OF REVIEW: The association between thrombosis and malignancy in adults is well known. Children are now surviving malignancies that previously resulted in mortality. Complications, however, occur including thrombosis that result in mortality and morbidity. This review will explore the association in children and discuss the epidemiology and evidence-based diagnosis and treatment of thrombosis in this cohort. RECENT
FINDINGS: Thrombin is an important link between malignancy, metastases, and inflammation. The accurate diagnosis of thrombosis in the upper venous system is directly related to the diagnostic technique used. Antithrombotic treatment is challenging owing to higher risks of bleeding, for example, decreased platelet counts, tiffelitis, large vascular tumor, etc.
SUMMARY: Thrombosis and malignancy are associated in children. Properly designed studies are urgently required to further define the epidemiology of thrombosis in different malignancies and to find the best way to diagnose and treat thrombosis in children.

Entities:  

Mesh:

Year:  2006        PMID: 16470154     DOI: 10.1097/01.mop.0000193270.09001.ea

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  8 in total

Review 1.  Upfront Therapies and Downstream Effects: Navigating Late Effects in Childhood Cancer Survivors in the Current Era.

Authors:  Rachel Phelan; Hesham Eissa; Kerri Becktell; Neel Bhatt; Matthew Kudek; Brandon Nuechterlein; Lauren Pommert; Ryuma Tanaka; K Scott Baker
Journal:  Curr Oncol Rep       Date:  2019-11-25       Impact factor: 5.075

2.  Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study.

Authors:  Lesley Mitchell; Moritz Lambers; Silke Flege; Gili Kenet; Valerie Li-Thiao-Te; Susanne Holzhauer; Christoph Bidlingmaier; Michael C Frühwald; Christine Heller; Wolfgang Schmidt; Brigitte Pautard; Ulrike Nowak-Göttl
Journal:  Blood       Date:  2010-03-25       Impact factor: 22.113

3.  Pediatric venous thromboembolism in the United States: a tertiary care complication of chronic diseases.

Authors:  Bhuvana A Setty; Sarah H O'Brien; Bryce A Kerlin
Journal:  Pediatr Blood Cancer       Date:  2011-10-28       Impact factor: 3.167

Review 4.  Mechanical compression versus subcutaneous heparin therapy in postoperative and posttrauma patients: a systematic review and meta-analysis.

Authors:  Robert W Eppsteiner; Jennifer J Shin; Jonas Johnson; Rob M van Dam
Journal:  World J Surg       Date:  2010-01       Impact factor: 3.352

5.  Cerebral venous sinus thrombosis in an adolescent with Ewing sarcoma.

Authors:  Ekrem Unal; Abdullah Yazar; Yavuz Koksal; Umran Caliskan; Yahya Paksoy; Erdal Kalkan
Journal:  Childs Nerv Syst       Date:  2008-05-15       Impact factor: 1.475

6.  Venous thromboembolism in children with cancer - a population-based cohort study.

Authors:  Alex J Walker; Matthew J Grainge; Tim R Card; Joe West; Susanna Ranta; Jonas F Ludvigsson
Journal:  Thromb Res       Date:  2013-12-21       Impact factor: 3.944

7.  TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial.

Authors:  Irene L M Klaassen; Mandy N Lauw; Marianne D van de Wetering; Bart J Biemond; Saskia Middeldorp; Floor C H Abbink; Marc Bierings; D Maroeska M W Te Loo; Rob Pieters; Inge M van der Sluis; Wim J E Tissing; C Michel Zwaan; C Heleen van Ommen
Journal:  BMC Pediatr       Date:  2017-05-10       Impact factor: 2.125

8.  Do children with central venous line (CVL) dysfunction have increased risk of symptomatic thromboembolism compared to those without CVL-dysfunction, while on cancer therapy?

Authors:  Jacqueline Halton; Kim Nagel; Leonardo R Brandão; Mariana Silva; Paul Gibson; Anthony Chan; Kay Blyth; Kim Hicks; Nagina Parmar; Leslie Paddock; Stephanie Willing; Lehana Thabane; Uma Athale
Journal:  BMC Cancer       Date:  2012-07-26       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.